Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Brain structural connectivity in late-life major depressive disorder.
Shared and Distinct Patterns of Oligodendroglial Response in α-Synucleinopathies and Tauopathies.
The Role of Biogenic Amines in the Regulation of Interaction between the Immune and Nervous Systems in Multiple Sclerosis.
Is my MS patient failing treatment?
Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair.
3D-DIR for early differential diagnostic and prognostic evaluation of NMO.
Major depressive disorder.
Multiple sclerosis patients need and want information on exercise promotion from healthcare providers: a qualitative study.
Poster 200 Demyelinating Polyneuropathy Post-Operatively in a Patient with Squamous Cell Carcinoma of the Tongue: A Case Report.
Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial.
Time and brain health both matter in multiple sclerosis.
Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Kynurenic Acid Induces Impairment of Oligodendrocyte Viability: On the Role of Glutamatergic Mechanisms.
Subcellular Optogenetic Stimulation for Activity-Dependent Myelination of Axons in a Novel Microfluidic Compartmentalized Platform.
Influence of a low dose of silver nanoparticles on cerebral myelin and behavior of adult rats.
Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders.
Poster 347 Physical Therapy Utilization in the Management of Multiple Sclerosis in the United States.
Walking impairs cognitive performance among people with multiple sclerosis but not controls.
Comprehension of confidence intervals - development and piloting of patient information materials for people with multiple sclerosis: qualitative study and pilot randomised controlled trial.
Myelin-targeted, texaphyrin-based multimodal imaging agent for magnetic resonance and optical imaging.
Neuroimmunological Implications of AQP4 in Astrocytes.
Reorganization of Lipid Diffusion by Myelin Basic Protein as Revealed by STED Nanoscopy.
Evaluation and management of longitudinally extensive transverse myelitis: a guide for radiologists.
Individual Differences in the Alignment of Structural and Functional Markers of the V5/MT Complex in Primates.
Improvement of neurological disorders in postmenopausal model rats by administration of royal jelly.
Pages
« first
‹ previous
…
746
747
748
749
750
751
752
753
754
…
next ›
last »